Center for Alternatives to Animal Testing, CAAT-Europe, University of Konstanz, Konstanz, Germany.
Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.
ALTEX. 2021;38(1):140-150. doi: 10.14573/altex.2010062.
The use of new approach methodologies (NAMs) in support of read-across (RAx) approaches for regulatory purposes is a main goal of the EU-ToxRisk project. To bring this forward, EU-ToxRisk partners convened a workshop in close collaboration with regulatory representatives from key organizations including European regulatory agencies, such as the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA), as well as the Scientific Committee on Consumer Safety (SCCS), national agencies from several European countries, Japan, Canada and the USA, as well as the Organisation for Economic Cooperation and Development (OECD). More than a hundred people actively participated in the discussions, bringing together diverse viewpoints across academia, regulators and industry. The discussion was organized starting from five practical cases of RAx applied to specific problems that offered the oppor-tunity to consider real examples. There was general consensus that NAMs can improve confidence in RAx, in particular in defining category boundaries as well as characterizing the similarities/dissimilarities between source and target substances. In addition to describing dynamics, NAMs can be helpful in terms of kinetics and metabolism that may play an important role in the demonstration of similarity or dissimilarity among the members of a category. NAMs were also noted as effective in providing quanti-tative data correlated with traditional no observed adverse effect levels (NOAELs) used in risk assessment, while reducing the uncertainty on the final conclusion. An interesting point of view was the advice on calibrating the number of new tests that should be carefully selected, avoiding the allure of "the more, the better". Unfortunately, yet unsurprisingly, there was no single approach befitting every case, requiring careful analysis delineating the optimal approach. Expert analysis and assessment of each specific case is still an important step in the process.
在监管目的中,使用新方法方法(NAMs)来支持(RAx)方法是欧盟-ToxRisk 项目的主要目标。为了推进这一目标,欧盟-ToxRisk 合作伙伴与来自关键组织的监管代表密切合作,召开了一次研讨会,这些组织包括欧洲监管机构,如欧洲化学品管理局(ECHA)和欧洲食品安全局(EFSA),以及消费者安全科学委员会(SCCS),来自几个欧洲国家、日本、加拿大和美国的国家机构,以及经济合作与发展组织(OECD)。超过 100 人积极参与了讨论,汇集了学术界、监管机构和行业的不同观点。讨论是从五个实际的 RAx 案例开始组织的,这些案例针对特定的问题提供了考虑实际例子的机会。人们普遍认为,NAMs 可以提高 RAx 的可信度,特别是在定义类别边界以及表征源物质和目标物质之间的相似性/差异性方面。除了描述动力学外,NAMs 在动力学和代谢方面也可能在证明类别成员之间的相似性或差异性方面发挥重要作用,因此也很有帮助。NAMs 还被认为在提供与风险评估中使用的传统无观察不良效应水平(NOAELs)相关的定量数据方面是有效的,同时减少了对最终结论的不确定性。一个有趣的观点是关于校准应仔细选择的新测试数量的建议,避免“越多越好”的诱惑。不幸的是,这并不出人意料,没有一种方法适合每种情况,需要仔细分析确定最佳方法。对每个具体案例的专家分析和评估仍然是该过程的重要步骤。